Literature DB >> 8675102

Acute liver damage and ecstasy ingestion.

A J Ellis1, J A Wendon, B Portmann, R Williams.   

Abstract

Eight cases of ecstasy related acute liver damage referred to a specialised liver unit are described. Two patients presented after collapse within six hours of ecstasy ingestion with hyperthermia, hypotension, fitting, and subsequently disseminated intravascular coagulation with rhabdomyolysis together with biochemical evidence of severe hepatic damage. One patient recovered and the other with evidence of hyperacute liver failure was transplanted but subsequently died, histological examination showing widespread microvesicular fatty change. Four patients presented with acute liver failure without hyperthermia. All four fulfilled criteria for transplantation, one died before a donor organ became available, and two died within one month post-transplantation of overwhelming sepsis. Histological examination showed submassive lobular collapse. Two patients presented with abdominal pain and jaundice and recovered over a period of three weeks; histological examination showed a lobular hepatitis with cholestasis. Patients developing jaundice or with evidence of hepatic failure particularly encephalopathy and prolongation of the international normalised ratio, or both, whether or not preceded by hyperthermia, should be referred to a specialised liver unit as liver transplantation probably provides the only chance of recovery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675102      PMCID: PMC1383078          DOI: 10.1136/gut.38.3.454

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Misuse of ecstasy.

Authors:  J D Shearman; R W Chapman; J Satsangi; N G Ryley; S Weatherhead
Journal:  BMJ       Date:  1992-08-01

2.  Attached, detached, or new recruits?

Authors:  C Martin
Journal:  BMJ       Date:  1992-08-08

3.  Heatstroke and rhabdomyolysis presenting as fulminant hepatic failure.

Authors:  S Fidler; E Fagan; R Williams; I Dewhurst; C E Cory
Journal:  Postgrad Med J       Date:  1988-02       Impact factor: 2.401

4.  Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat.

Authors:  C J Gordon; W P Watkinson; J P O'Callaghan; D B Miller
Journal:  Pharmacol Biochem Behav       Date:  1991-02       Impact factor: 3.533

5.  Liver failure occurring as a component of exertional heatstroke.

Authors:  T Hassanein; J A Perper; L Tepperman; T E Starzl; D H Van Thiel
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

Review 6.  Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').

Authors:  B Tehan; R Hardern; A Bodenham
Journal:  Anaesthesia       Date:  1993-06       Impact factor: 6.955

7.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Authors:  J A Henry; K J Jeffreys; S Dawling
Journal:  Lancet       Date:  1992-08-15       Impact factor: 79.321

8.  [Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')].

Authors:  R A de Man; J H Wilson; H S Tjen
Journal:  Ned Tijdschr Geneeskd       Date:  1993-04-03

9.  Early indicators of prognosis in fulminant hepatic failure.

Authors:  J G O'Grady; G J Alexander; K M Hayllar; R Williams
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

10.  Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia.

Authors:  I S Chadwick; P D Curry; A Linsley; A J Freemont; B Doran
Journal:  J R Soc Med       Date:  1991-06       Impact factor: 18.000

View more
  20 in total

1.  Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology.

Authors:  J Devlin; J O'Grady
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 2.  Ten years of 'ecstasy'.

Authors:  C M Milroy
Journal:  J R Soc Med       Date:  1999-02       Impact factor: 5.344

3.  Ecstasy-induced myocardial infarction in a teenager: rare complication of a widely used illicit drug.

Authors:  Michael Möller; Jens Völz; Robert Paliege; Corinna Lenz; Rainer Gradaus; Jörg Neuzner
Journal:  Clin Res Cardiol       Date:  2010-09-07       Impact factor: 5.460

Review 4.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

Review 5.  [1997 gastroenterology update--II].

Authors:  W Fischbach; V Gross; J Schölmerich; C Ell; P Layer; W E Fleig
Journal:  Med Klin (Munich)       Date:  1998-03-15

6.  Management of drug abuse emergencies.

Authors:  J A Henry
Journal:  J Accid Emerg Med       Date:  1996-11

Review 7.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

8.  "Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series.

Authors:  C M Milroy
Journal:  Forensic Sci Med Pathol       Date:  2011-01-25       Impact factor: 2.007

9.  Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy").

Authors:  Vijay V Upreti; Natalie D Eddington; Kwan-Hoon Moon; Byoung-Joon Song; Insong J Lee
Journal:  Toxicol Lett       Date:  2009-04-05       Impact factor: 4.372

10.  Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated mitochondrial dysfunction in rat liver.

Authors:  Kwan-Hoon Moon; Vijay V Upreti; Li-Rong Yu; Insong J Lee; Xiaoying Ye; Natalie D Eddington; Timothy D Veenstra; Byoung-Joon Song
Journal:  Proteomics       Date:  2008-09       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.